SAU : 4015.SR

Jamjoom Pharmaceuticals Factory Company

$146.5 SAR

-$0.1 (-0.07%)

Volume
16.2K
Average Volume
38.33K
Market Capitalization
$10.26B
P/E Ratio
21.51
Dividend Yield
2.73%
Price Target
Year High
$179.30
Year Low
$125.00
Day High
—
Day Low
—
Payout Ratio
$0.59
Current Ratio
$4.94
Company Overview

SAU

Tarek Youssef Hussein Hosni

Drug Manufacturers - Specialty & Generic

Healthcare

4015.SR

1079

SA

SAR

https://www.jamjoompharma.com

966 12 608 1111

N/A

N/A

Liquidity Metrics

0.01

4.94

4.15

0.77

0.59

Sales & Valuation

$1.5B

6.73

5.94

27.87

5.25

Profitability

$6.6

$463.8M

31.16%

33.08%

28.02%

22.51%

P/E Metrics

21.51

1.34

1.34

Analyst Price Target & Rating

Buy

4/5

0 Analysts

%

Financial Health Scores

19.07

6/9

$1.05B

$2.11B

$380.45M

$485.33M

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Anjum Latif Director of Corporate Procurement and Head of Manufacturing & Facilities Business Operations
Ahmed Yousuf Mohammed Salah Jamjoom Executive Vice Chairman
Anwer Mohiuddin Chief Financial Officer
Faisal Ahmed Ibrahim Linjawi Board Secretary
Idrees Ahmed Siddiqui Head of Manufacturing Operations
Mazen Al Serehi Human Resources Director
Anjum Lateef Director of Corporate Procurement and Head of Manufacturing & Facilities Business Operations
Mohammed Mahmoud Jamjoom Associate Director of Public Affairs & Head of Business Operations
Tarek Youssef Hussein Hosni Chief Executive Officer
Hussam Salousa Head of Business Development & Strategy and IR Director
Poll Results

No votes yet today — be the first to share your view!

About Jamjoom Pharmaceuticals Factory Company (SAU:4015.SR) Stock

Established in 1994, Jamjoom Pharmaceuticals Factory Company, headquartered in Jeddah, Saudi Arabia, is a key player in the production and commercialization of medicinal products. The firm serves markets both within the Kingdom of Saudi Arabia and across various international regions. Its extensive product portfolio addresses a wide array of therapeutic needs, covering ophthalmology, dermatology, gastrointestinal issues, cardiovascular health, central nervous system disorders, as well as general medicine, over-the-counter remedies, and nutraceuticals/consumer health products. ...

Frequently Asked Questions

What is the current Jamjoom Pharmaceuticals Factory Company (4015.SR) stock price?

Jamjoom Pharmaceuticals Factory Company(SAU:4015.SR) stock price is $146.5 in the last trading session. During the trading session, 4015.SR stock reached the peak price of $179.3 while $125 was the lowest point it dropped to. The percentage change in 4015.SR stock occurred in the recent session was --0.07% while the dollar amount for the price change in 4015.SR stock was -$0.1.

4015.SR's industry and sector of operation?

The SAU listed 4015.SR is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of 4015.SR?

Anjum Latif | Director of Corporate Procurement and Head of Manufacturing & Facilities Business Operations
Ahmed Yousuf Mohammed Salah Jamjoom | Executive Vice Chairman
Anwer Mohiuddin | Chief Financial Officer
Faisal Ahmed Ibrahim Linjawi | Board Secretary
Idrees Ahmed Siddiqui | Head of Manufacturing Operations

How many employees does 4015.SR have?

Number of 4015.SR employees currently stands at 1079. 4015.SR operates from Industrial Area, Jeddah, MC 21442, SA.

Link for 4015.SR official website?

Official Website of 4015.SR is: https://www.jamjoompharma.com

How do I contact 4015.SR?

4015.SR could be contacted at phone #966 12 608 1111 and can also be accessed through its website. 4015.SR operates from Industrial Area, Jeddah, MC 21442, SA.

How many shares of 4015.SR are traded daily?

The average number of 4015.SR shares traded daily for last 3 months was 38.33K.

What is the market cap of 4015.SR currently?

The market value of 4015.SR currently stands at $10.26B with its latest stock price at $146.5